缺失组织因子途径抑制物β或γ亚型而非α亚型可改善血友病小鼠的凝血功能
在血友病(因子VIII缺失)小鼠中,评估组织因子途径抑制物(TFPI)各亚型特异性缺失对凝血的影响。结果显示,TFPIβ或TFPIγ缺失可改善凝血,而TFPIα缺失无影响;杂合缺失TFPIβ有效,杂合缺失TFPIα或TFPIγ单独无效,但杂合缺失TFPIαγ可改善凝血。
要点
- 血友病小鼠中,TFPIβ或TFPIγ缺失改善凝血至14.6次和15.2次,而TFPIα缺失无影响(5.1次)。
- 杂合缺失TFPIβ有效(11.8次),杂合缺失TFPIα或TFPIγ单独无效(3.0次和6.1次),杂合缺失TFPIαγ改善至11.2次。
- 小鼠血浆中TFPIγ是主要的抗凝亚型。
核心结论
- 在血友病小鼠中,内皮TFPIβ和血浆γ来源的2-Kunitz TFPI各自对出血的贡献大于总TFPIα。
研究设计与样本
- 研究使用工程化的TFPI亚型特异性缺失且因子VIII缺失的血友病小鼠评估凝血功能。
主要发现
- 表达任一单一TFPI亚型的小鼠健康。
- 凝血酶生成试验确定TFPIγ是小鼠血浆中主要的抗凝亚型。
- C57BL/6小鼠和血友病小鼠平均凝血次数分别为25.6次和5.4次。
- 血友病背景下,TFPIβ或TFPIγ特异性缺失分别改善凝血至14.6次和15.2次(P < .0001)。
- TFPIα特异性缺失无影响,凝血5.1次。
关键数值与推荐
- 杂合缺失TFPIβ有效,凝血11.8次(P < .0001)。
- 杂合缺失TFPIα或TFPIγ单独无效,凝血分别为3.0次和6.1次,但杂合缺失TFPIαγ改善凝血至11.2次(P < .001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tissue factor pathway inhibitor (TFPI) regulates tissue factor-triggered coagulation. Humans and mice express transcripts encoding for multidistributed (endothelial, platelet, and plasma) 3-Kunitz domain TFPIα and endothelial membrane-anchored 2-Kunitz TFPIβ. Mice express a third transcript, γ, that encodes plasma lipoprotein-associated 2-Kunitz TFPI. In humans, proteolysis of α and/or β produces plasma lipoprotein-associated 2-Kunitz TFPI at lower levels. In clinical trials, monoclonal antibodies that target all TFPI isoforms extend coagulation and correct bleeding in hemophilic patients but with some thrombosis risks. OBJECTIVES: To determine the impact of TFPI isoform-specific deletions on promoting clotting in hemophilic mice. METHODS: Engineered TFPI isoform-specific, hemophilic (factor VIII-null) mice were evaluated for clotting. RESULTS: Mice expressing any single TFPI isoform were healthy. Thrombin generation assays identified TFPIγ as the dominant anticoagulation isoform in mouse plasma. Hemostasis was assessed by serial bleeding times from a tail vein laceration. Repeatedly, after a clot forms, it was manually disrupted; the number of clots/disruptions occurring over a 15-minute period were reported. C57BL/6 and hemophilic mice clot on average 25.6 vs 5.4 times, respectively. On a hemophilia background, TFPIβ or TFPIγ-specific deletion improved clotting to 14.6 and 15.2 times, respectively (P < .0001). TFPIα-specific deletion was without impact, clotting 5.1 times. Heterozygous deletion of TFPIβ was effective, clotting 11.8 times (P < .0001). Heterozygous deletion of TFPIα or TFPIγ alone was ineffective, clotting 3.0 and 6.1 times, respectively, but heterozygous TFPIαγ deletion improved clotting to 11.2 times (P < .001). CONCLUSION: In hemophilic mice, endothelial TFPIβ and plasma γ-derived 2-Kunitz TFPI individually contribute more to bleeding than total TFPIα.
引用
- Eldem I, Antunes-Heck L, Subramanian R, et al. Deletion of tissue factor pathway inhibitor isoform beta or gamma, but not alpha, improves clotting in hemophilic mice. J Thromb Haemost. 2024. PMID: 38925489. doi:10.1016/j.jtha.2024.06.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。